Trial Profile
Clinical Trials Insight: 700053730
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2010
Price :
$35
*
At a glance
- Drugs Etoposide-toniribate (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Sponsors CellAct Pharma
- 16 Oct 2009 New trial record